Blog

Oscar Borja Montes: Gender Disparity in Enrollment in Clinical Trials for Hairy Cell Leukemia Treatments

Oscar Borja Montes/X

May 24, 2025, 13:11

Oscar Borja Montes: Gender Disparity in Enrollment in Clinical Trials for Hairy Cell Leukemia Treatments

Oscar Borja Montes, Hem/Onc Fellow at the University of Florida, posted on X:

“Why is it important to research on healthcare disparities?

We found in this observational study that female patients with hairy cell leukemia are disproportionately less likely to be enrolled in clinical trials for experimental treatments. Here our most recent publication on the European Journal of Haematology.”

Title: Gender Disparity in Enrollment in Clinical Trials for Hairy Cell Leukemia Treatments in the Last 40 Years

Authors: Oscar F. Borja-Montes, Anna Bode, Tomas Escobar-Gil, Alejandro Toro-Pedroza, Narandranath Epperla, Leslie A. Andritsos

Read The Full Article at European Journal of Haematology.

Oscar Borja Montes: Gender Disparity in Enrollment in Clinical Trials for Hairy Cell Leukemia Treatments

More posts featuring Leukemia.

Alejandro Toro-Pedroza Anna Bode cancer European Journal of Haematology Hairy Cell Leukemia Leslie A. Andritsos Leukemia Narandranath Epperla OncoDaily Oncology Oscar Borja Montes Tomas Escobar-Gil

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers